Core Laboratories N.V.

NYSE: CLB · Real-Time Price · USD
10.61
-0.13 (-1.21%)
At close: Aug 14, 2025, 3:59 PM
10.60
-0.09%
Pre-market: Aug 15, 2025, 08:45 AM EDT

Core Laboratories Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
19.16M 15.12M 15.43M 17.7M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
5.08M 4.84M 4.45M 4.16M
Other Long-Term Assets
29.71M 98.58M 29.3M 37.26M
Receivables
127.36M 123.07M 115.1M 106.74M
Inventory
59.4M 71.7M 60.45M 45.44M
Other Current Assets
10.52M 5.09M 5.06M 5.11M
Total Current Assets
226.61M 223.14M 211.7M 189.06M
Property-Plant & Equipment
153.55M 153.47M 157.41M 172.34M
Goodwill & Intangibles
105.85M 106.37M 106.93M 107.58M
Total Long-Term Assets
363.8M 363.26M 366.65M 391.8M
Total Assets
590.41M 586.39M 578.35M 580.85M
Account Payables
34.55M 33.51M 45.85M 29.73M
Deferred Revenue
9.33M 4.75M 5.94M 7.76M
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
31.06M 13.59M 13.18M 13.61M
Total Current Liabilities
97.59M 88.1M 103.14M 90.78M
Long-Term Debt
126.11M 163.13M 172.39M 188.64M
Other Long-Term Liabilities
51.85M 20.04M 20.88M 27.71M
Total Long-Term Liabilities
235.08M 268.49M 286.26M 329.07M
Total Liabilities
332.67M 356.59M 389.4M 419.85M
Total Debt
180.14M 215.38M 222.39M 250.26M
Common Stock
470K 469K 1.19M 1.19M
Retained Earnings
150.28M 120.76M 85.95M 68.35M
Comprehensive Income
-5.77M -4.97M -3.78M -10.13M
Shareholders Equity
251.99M 224.81M 184.26M 156.45M
Total Investments
5.08M 4.84M 4.45M 4.16M